Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Dana Genetic A/S
A/S
Dissolved
CVR 37298182
Grusbakken 2D, 2820
Gentofte
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2015 · 10 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Dana Genetic A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (1)
HH
Hans-Ole Hedegaard
Chief Executive Officer
Chief Executive Officer
2015 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Former (5)
ML
Michael Lützhøft Hansen
Chairman
Chairman
2017 – 2023
HH
Hans-Ole Hedegaard
Board of Directors
Board of Directors
2015 – 2023
KB
Kurt Bækgaard Osther
Chairman
Chairman
2015 – 2017
JO
Joachim Osther
Board of Directors
Board of Directors
2017 – 2017
KJ
Kasper Juul Hedegaard
Board of Directors
Board of Directors
2015 – 2023
Shareholders
As of last annual report
Osther Consulting LLC — 33.33–49.99%
Pharmagen ApS — 100%
HOLDINGSELSKABET MLH ApS — 33.33–49.99%
100%
Shareholder
Type
Ownership
Votes
Since
Osther Consulting LLC
Company
33.33–49.99%
33.33–49.99%
2016
Pharmagen ApS
Company
100%
100%
2022
HOLDINGSELSKABET MLH ApS
Company
33.33–49.99%
33.33–49.99%
2017
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Dana Genetic A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network